ArticleMedComm2026

Tislelizumab Combined With Axitinib in Neoadjuvant Treatment of Locally Advanced Clear Cell Renal Cell Carcinoma: A Single-Center, Phase II Clinical Study.

Wenjin Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.